Dynamic gadolinium DTPA-enhanced magnetic resonance of intravascular stents

In vitroevaluation of stent patency and in-stent stenoses in 10 metallic stents using MR angiography

In vitro study to investigate the suitability of contrast enhanced magnetic resonance angiography (CEMRA) for determination of stent patency and grading of in-stent stenoses in 10 metallic stents. The Acculink carotid, DynaLink, Easy Wallstent, JostentSelfX XF, Luminexx, Omnilink, sinus-SuperFlex, SMART, Symphony and ZA stent were separately placed in a vascular phantom. Dedicated stenoses inside the stents generated a concentric lumen narrowing of 50%. CEMRA was performed for each stent. Signal loss inside the stents and artificial lumen narrowing were assessed objectively using the evaluation software of the MR imager. Moreover, three blinded observers determined visibility of stent patency and in-stent stenoses subjectively on a 3-point scale and graded in-stent stenoses. Loss of signal intensity within the stent lumen ranged between 90% (Wallstent) and 5% (ZA), artificial lumen narrowing between 56% (Symphony) and 22% (ZA). For the Symphony and Wallstent, visibility of patency and in-stent stenoses was impaired and the observers' grading exaggerated the degree of stenoses (by 23% and 33%, respectively). For the remainder of stents, patency and stenoses were visible and stenoses were graded accurately (less than 10% discrepancy from reference standard). In this in vitro study, eight of 10 stents presented with MRI characteristics which enabled determination of stent patency and accurate grading of clinically relevant in-stent stenoses.

In Vivo Evaluation of Patency and In-Stent Stenoses After Implantation of Nitinol Stents in Iliac Arteries Using MR Angiography

OBJECTIVE

Our study was a prospective in vivo study to evaluate whether MR angiography is suitable for assessing stent patency and grading in-stent stenoses and to examine whether the accuracy of MR angiography changes with time after stent implantation.

SUBJECTS AND METHODS

In a prospective study, 34 iliac stenoses in 27 patients were treated by implantation of 35 nitinol stents. MR angiography was performed immediately after stent placement for 32 stents, and both digital subtraction angiography (DSA) and MR angiography were repeated at the 6-month follow-up for 23 stents. Three blinded observers assessed stent patency and the degree of in-stent stenoses on MR angiography and DSA (the standard of reference) images. The difference between the observers' grading of stenoses on DSA and on MR angiography was determined. Statistical analysis was performed using the Student's t test for paired samples.

RESULTS

Stent patency was assessed correctly for all stents and both sets of MR angiography images. Evaluation of DSA 1 images (obtained at end of implantation procedure) revealed that 96.9% of in-stent stenoses were less than 50%. On DSA 2 images (obtained at follow-up), 95.7% of in-stent stenoses were graded as less than 50%. The difference between grading of stenoses on DSA and MR angiography images was 15.0% +/- 16.0% (minimum, 0.0%; maximum, 63.3%) for DSA 1 versus MR angiography 1 (statistically significant, p = 0.037) and 9.8% +/- 13.5% (minimum, 0.0%; maximum, 63.3%) for MR angiography 2 versus DSA 2 (not statistically significant, p = 0.355).

CONCLUSION

Patency was correctly assessed for all stents on MR angiography. The quality of MR angiography regarding characterization of in-stent stenoses improved with time after stent placement. However, discrepancies of more than 60% between grading of lumen narrowing on DSA and MR angiography images occurred even at the 6-month follow-up. Thus, MR angiography is not yet a reliable technique for characterization of in-stent stenoses.

Human peripheral arteries: feasibility of transvenous intravascular MR imaging of the arterial wall

Feasibility of in vivo transvenous intravascular magnetic resonance (MR) imaging of the human arterial wall was determined. All subjects provided written informed consent, and institutional review board approved the study. Six arteries in six patients were imaged with a guidewire placed in the iliac vein (n = 5) or left renal vein (n = 1). Pre- and postcontrast T1-weighted and T2-weighted transvenous MR imaging were performed. An atherosclerotic plaque with a fibrous cap was identified on 27 (42%) of 64 images of veins without stents; intimal hyperplasia in a renal artery with a stent was identified on 12 images. Contrast-to-noise ratios (CNRs) on arterial wall postcontrast T1-weighted images were superior to those on images obtained with other sequences (P < .001), and the postcontrast images demonstrated the greatest number of plaques with a low-signal intensity core and fibrous cap. Preliminary results show that transvenous MR imaging is feasible for high-spatial-resolution imaging of the arterial wall and atherosclerotic plaque. Postcontrast T1-weighted imaging affords greatest CNR for the arterial wall.

Gadopentetate dimeglumine-enhanced three-dimensional MR-angiography: dosing, safety, and efficacy

Noninvasiveness, inherent three-dimensionality allowing reformations in any desired plane, and safe contrast agents, coupled with high diagnostic accuracy have driven the rise in popularity of contrast-enhanced MR angiography (CE-MRA) within the medical community. Reflecting its dominant market share as a paramagnetic contrast agent, gadopentetate dimeglumine (Gd-DTPA) has been used for the majority of clinically-performed MRA exams. Over the period January 1994 to February 2002, a total of 172 original studies describing the use of gadolinium-enhanced MRA in more than three human subjects were identified. Of these, 117 described the use of Gd-DTPA as the contrast agent for MRA. A total of 4046 subjects who received Gd-DTPA for MRA are described in these studies. Analysis of these data demonstrate Gd-DTPA to be a safe contrast agent for MRA when applied in a dose ranging from 0.1 to 0.3 mmol/kg of bodyweight. The documented clinical results show Gd-DTPA to be efficacious in the assessment of the arterial system. The effectiveness of Gd-DTPA-enhanced MRA extends beyond the detection, localization, and characterization of arterial disease, and encompasses choice and planning of appropriate therapy, as well as evaluation of therapeutic effectiveness.

T2 dark blood MRA for renal artery stenosis detection: preliminary observations

OBJECTIVE

This study evaluated the ability of a fast spin echo T2 weighted dark blood sequence to characterize significant (>50%) renal artery stenosis compared to conventional angiography.

METHODS

Sixteen patients underwent conventional catheter angiography for either renal artery stenosis evaluation or as potential renal donors. Each patient then had an MR study of the renal arteries and kidneys with fast spin echo T2 weighted MR (TR 4000, TE 102, 8 echo train length) on a Superconducting 1.5T Magnet. Results were compared with angiography and inter and intra observer statistics were calculated.

RESULTS

A total of 36 renal arteries were imaged in 32 kidneys with 12 stenoses >50%. Fast spin echo T2 weighted MR is 94% accurate (95%CI: 87-100%) in detection of significant renal artery stenosis. Dark blood MRA (DBMRA) is 96% sensitive (95%CI: 89-100), 92% specific, with a predictive value positive of 96% for classifying real arteries as normal or significantly stenosed. Inter and intra observer statistics demonstrate good to excellent agreement in renal artery classification (kappa>0.60).

CONCLUSION

DBMRA may be a useful adjunct to renal MR evaluation in hypertension.

SUMMARY

A total of 36 renal arteries were imaged in 32 kidneys with 12 stenoses >50%. Fast spin echo T2 weighted MR is 94% accurate (95%CI: 87-100%) in detection of significant renal artery stenosis.

Quantitative evaluation of susceptibility and shielding effects of nitinol, platinum, cobalt-alloy, and stainless steel stents

The purpose of this study is to quantitatively estimate the shielding and susceptibility effects of commonly used metallic stents on MR signal. Two experiments were performed using a 3D gradient echo sequence with short TE to image a stent phantom: 1) short TR and high flip angle (contrast enhanced MRA parameters), and 2) long TR (TR >> T(1)) and low flip angle. The factor characterizing susceptibility effects was estimated from the signal phase of the first experiment, and then the factor characterizing the shielding effects was derived from the second experiment. Susceptibility induced signal loss was negligible (<1%) for nonstainless-steel (nitinol, platinum, and cobalt-alloy) stents and totally destructive (100%) for the stainless steel stent. Signal loss due to RF shielding was 31-62% for nitinol stents, 14-50% for platinum stents, 50-77% for the cobalt-alloy stents (undetermined for the stainless steel stent), varied with stent orientation, diameter, and wall geometry. In summary, stents made of nitinol, platinum, and cobalt-alloy have negligible susceptibility effects but stents made of stainless steel may have complete dephasing. All stents have substantial shielding effects, which vary with composition, geometry, and orientation. Large platinum stents may have the smallest artifacts and are the best suited for postinterventional MR imaging.

Vascular MRI in the diagnosis and therapy of the high risk atherosclerotic plaque

Disruption of a high risk plaque is known as the primary cause of cardiovascular events. Characterization of arterial wall components has become an essential adjunct in the identification of patients with plaques prone to rupture. Magnetic Resonance Imaging (MRI) has been revealed as one of the noninvasive tools possibly capable of identifying and characterizing high risk atherosclerotic plaque. MRI may facilitate diagnosis, and guide and serially monitor interventional and pharmacological treatment of atherosclerotic disease. In addition, it permits the simultaneous assessment of the anatomy, morphology, and hemodynamics for the study of flow-induced atherogenesis. It possibly will identify asymptomatic patients with subclinical atherosclerosis. This has potential significance for the improvement of strategies in primary and secondary prevention.

A vascular stent as an active component for locally enhanced magnetic resonance imaging: initial in vivo imaging results after catheter-guided placement in rabbits

RATIONALE AND OBJECTIVE

A vascular stent constructed as a high frequency resonator improves the local signal-to-noise ratio at magnetic resonance (MR) imaging. After catheter placement and intravascular expansion, the stent can be used as an inductively coupled coil for MRI. The imaging properties of this balloon-expandable active MRI stent (AMRIS) were evaluated after x-ray fluoroscopy guided placement in the abdominal aorta of five rabbits using MR angiography (MRA) and flow measurements.

METHODS

The AMRIS was implanted in the abdominal aorta of five rabbits using a balloon catheter inserted through the common carotid artery. The rabbits were examined by MRA (3D fast low-angle shot) at 1.5 tesla before and after intravenous injection of an iron-oxide-based blood pool contrast medium (dose 50 micro mol Fe/kg) and flow measurements (ECG-triggered phase contrast cine gradient-echo sequence). Signal-to-noise ratios (SNR) were calculated and flow volume curves were generated. The in-stent increase in temperature was measured in vitro using a fiberoptic thermometry system.

RESULTS

The SNR was 5.0 +/- 0.6 outside the stent and 23.2 +/- 14.1 within the stent ( < 0.0 5) in plain MRA, 19.5 +/- 5.0 outside and 30.7 +/- 8.2 within the stent ( < 0.05) in contrast enhanced MRA, and 5.8 +/- 1.6 and 13.9 +/- 5.9, respectively ( < 0.05) in the magnitude images of the flow measurements. Flow volume curves within and distal to the stent were comparable.

CONCLUSIONS

The expandable active MRI stent produces local signal enhancement in MRA and MR flow measurements after catheter placement and thus may improve assessment of the stented vessel segment by MR imaging.

Volume-rendered multidetector CT angiography: noninvasive follow-up of patients treated with renal artery stents

OBJECTIVE

The purpose of our study was to evaluate the role of multidetector CT (MDCT) angiography with volume rendering for estimating the patency of renal artery stents.

SUBJECTS AND METHODS

In 16 patients, 16 renal artery stents were evaluated with MDCT renal angiography and digital subtraction angiography (DSA). CT data were evaluated using multiplanar volume reformations and the volume-rendering algorithm with three different volume-rendered parameter settings (low-to-high, high-to-low, and high-low-high opacity transfer functions: VR(LH), VR(HL), and VR(VE), respectively). Targeted images of each stent were rendered in paraaxial and paracoronal planes and were interactively interpreted. The overall restenosis severity was measured on postprocessed paraaxial and paracoronal images and compared with that obtained on DSA using linear regression analysis. Image quality and lumen delineation on rendered images were also compared using Wilcoxon's signed rank test.

RESULTS

Eight restenoses were identified on DSA. Correlations between restenosis severity measured with DSA and those measured with MDCT were significant (p < 0.001). Volume rendering with VR(HL) allowed the best correlation with DSA (reviewer 1, r(2) = 0.86; reviewer 2, r(2) = 0.94) and was significantly better than multiplanar volume reformations (p = 0.028). Overall image quality was high with all rendering techniques and with no significant differences (p > 0.59, for all comparisons). Stent lumen was well delineated with volume-rendering modalities; however, VR(HL) was significantly better than VR(LH) (p = 0.033).

CONCLUSION

Volume-rendered MDCT angiography enabled high-quality three-dimensional reproducible evaluation of the patency of implanted renal artery stents. Volume rendering with VR(HL) achieved the best performance.

Influence of blood-pool contrast media on MR imaging and flow measurements in the presence of pulmonary arterial stents in swine

PURPOSE

To compare the effects of various stents on magnetic resonance (MR) imaging flow volume measurements and to determine the value of a blood-pool MR imaging contrast medium in assessment of vascular stents.

MATERIALS AND METHODS

In 11 pigs, six nitinol stents (Memotherm), four platinum stents (NuMed), and one elgiloy stent (Wallstent) were placed in the main pulmonary artery under x-ray fluoroscopic guidance. MR imaging was performed 3 months after stent placement before and after injection of NC100150 contrast medium. Blood flow volumes were assessed with velocity-encoded cine MR imaging through and next to the stent. The signal-to-noise ratio and width of susceptibility artifacts of the stents also were determined. Measurements were analyzed with the paired Student t test and Bland-Altman test, where appropriate.

RESULTS

Blood flow volumes measured through the nitinol and platinum stents disclosed no significant difference between velocity-encoded cine MR imaging measurements through and next to the stent. On cine MR images, small susceptibility artifacts were observed around the nitinol and platinum stents. Signal-to-noise ratio in the stent lumen was reduced in nitinol and platinum stents when compared with that next to the stent. The elgiloy stent produced severe susceptibility artifacts, making measurement of flow volumes impossible. NC100150 injection caused no significant effect on flow volume measurements. It improved the signal-to-noise ratio of the pulmonary arterial lumen outside and, to a lesser extent, inside the stent.

CONCLUSION

Assessment of morphology and flow volumes through nitinol and platinum stents is feasible with MR imaging. Blood-pool contrast media provide persistent signal enhancement in the pulmonary artery and, to a lesser extent, in the lumina of nitinol and platinum stents.

Improved in-stent magnetic resonance angiography with high flip angle excitation

RATIONALE AND OBJECTIVES

To optimize the intraluminal signal intensity of a nitinol stent by performing contrast-enhanced three-dimensional magnetic resonance angiography (CE-MRA) with varying flip angles (FAs).

METHODS

Contrast-enhanced magnetic resonance angiography at 1.5 T and FAs of 30 degrees, 100 degrees, and 150 degrees was performed on five sheep with 10 iliac nitinol stents (Memotherm-FLEXX). Maximum-intensity projections (MIPs) and composite images of MIPs were performed and compared.

RESULTS

Reconstructed MIPs at an FA of 150 degrees showed a slightly disturbed lumen visibility inside the stent accompanied by low-grade lumen visibility outside the stent and vice versa for an FA of 30 degrees. Composite images of a 30 degrees MIP added to a 150 degrees MIP resulted in improved image quality compared with the standard MIP of a single FA.

CONCLUSIONS

Signal loss due to radiofrequency shielding inside nitinol stents imaged by CE-MRA can be reduced by applying high FAs. Composite MIP images allow simultaneous visualization of the lumen inside as well as outside the stent.

Treatment of renovascular disease with percutaneous stent insertion: long-term outcomes

Renal artery stenosis is a common, progressive cause of hypertension and renal impairment, and is frequently treated with percutaneous transluminal dilatation and stenting. The outcome of this procedure is still being evaluated. The records of 198 consecutive patients who had stents inserted at the Royal Melbourne Hospital were analysed retrospectively, and adequate follow-up information on 148 (75%), in whom a total of 182 renal arteries had been treated was obtained. Technical success was achieved in 144 patients (97%). Complications occurred in 19 patients (13.3%), with major complications occurring in 10 (7.0%) and one death occurring in relation to the procedure. A fall in average systolic blood pressure of 13.2 mmHg (12.1-14.3 mmHg) was seen and a fall in diastolic blood pressure of 10.1 mmHg (9.3-10.9 mmHg), without an increase in the number of antihypertensive drugs used. Renal function remained stable in the majority of patients, particularly those who had minimal baseline renal impairment. Restenosis was common after 6 months, occurring eventually in 29% of screened patients, but was not shown to affect clinical outcomes. Insertion of renal artery stents is a safe and effective treatment for renal artery stenosis.

The active magnetic resonance imaging stent (AMRIS): initial experimental in vivo results with locally amplified MR angiography and flow measurements

RATIONALE AND OBJECTIVES

Magnetic resonance (MR) is limited by artifacts in vessels after stenting. An active MR imaging stent (AMRIS) allows for artifact-free imaging with local improvement in signal-to-noise ratio (SNR). In a rabbit model, we evaluated the imaging properties by MR angiography (MRA) and flow measurements.

METHODS

The AMRIS was placed in the abdominal aorta of five rabbits. At 1.5 T, MRA (three-dimensional fast low-angle shot) was performed before and after intravenous injection of an iron oxide-based, blood-pool contrast medium (dose, 50 micromol Fe/kg), and flow measurements were performed (electrocardiographically triggered phase-contrast cine gradient-echo sequence). Mean SNRs were calculated and flow volume curves were generated.

RESULTS

The SNR was 6.0 +/- 0.6 (outside the stent) versus 12.3 +/- 1.1 (inside the stent, P < 0.05) for plain MRA, 21.2 +/- 0.6 versus 40.6 +/- 5.2 (P < 0.05) for contrast-enhanced MRA, and 5.4 +/- 0.4 versus 13.7 +/- 2.1 (P < 0.05) for the magnitude images of flow measurements. Flow volume curves within and distal to the stent were comparable.

CONCLUSIONS

By using the AMRIS as a vascular stent, the stented vessel segment can be examined with enhanced signal intensity on MRI.

In vitro evaluation of intravascular stent artifacts in three-dimensional MR angiography

RATIONALE AND OBJECTIVES

To evaluate the intraluminal signal characteristics of various stents and stent-grafts in contrast-enhanced three-dimensional MR angiography (3D MRA) in vitro.

METHODS

Fourteen stents made of different materials (steel, nitinol, tantalum, cobalt-based alloy, polyethylene) and six stent-grafts were implanted in plastic tubes simulating the common iliac artery. The tubes were filled with gadopentetate dimeglumine in water at a concentration of 25 mmol/L and positioned in a plastic container filled with water. For imaging, the container was placed in the center of the magnet, parallel, orthogonal, and diagonal to the z axis. A 3D gradient-echo sequence (T1-FFE) was acquired with the following parameters: repetition time 5.3 ms, echo time 1.6 ms, flip angle 50 degrees, slice thickness 1.5 mm, and acquisition matrix 256 with zero filling to 512. To evaluate the influence of the frequency-encoding gradient on the appearance of the artifacts, stents were examined with their axes oriented in all three directions both with the frequency-encoding gradient in the feet-head and right-left directions. The size and pattern of stent-related artifacts were evaluated semiquantitatively for each measurement.

RESULTS

Five different components of artifacts could be distinguished: homogeneous signal reduction inside the stent, narrowing of the stent lumen, structures of various shapes inside the stents, signal reduction or signal increase at the ends of the stents, and shift of the intraluminal signal orthogonal to the longitudinal axis of the vessel. The size of the artifacts depended heavily on the material of the stent. The polyethylene stent showed no artifacts, the tantalum stent only minor artifacts. Nitinol stents were characterized by artifacts at both ends and signal reduction intraluminally. Stents made of steel demonstrated the strongest artifacts, characterized by almost complete signal loss intraluminally. The characteristics of the artifacts of all stents depended on the direction of the stent relative to the frequency-encoding gradient.

CONCLUSIONS

Three-dimensional MRA follow-up after stent placement may be applicable for stent patency evaluation in all instances. However, grading of stenoses seems to be unrealistic in steel stents and in most nitinol stents.

MR evaluation of stent patency: in vitro test of 22 metallic stents and the possibility of determining their patency by MR angiography

RATIONALE AND OBJECTIVES

To determine the extent to which visualization of intrastent anatomy in stents of different composition and design is possible by using contrast-enhanced MR angiography.

METHODS

Twenty-two MR-compatible stents, most of which had a diameter of 8 mm, were positioned in a phantom filled with aqueous gadolinium solution. Coronal and axial spoiled three-dimensional gradient-echo sequences were performed. Images were acquired with stents positioned at varying angulations to the main magnetic field B0. Profiles orthogonal to the stent axis allowed measurement of artifact sizes independent of window width and center.

RESULTS

Oriented along B0, the Cragg, Corvita, Passager, Wallstent, Strecker, Impag, Perflex, and ZA stents allowed visualization of more than 48% of the lumen. The Memotherm, Smart, and Jostent SelfX stents showed a prominent reduction of the inner lumen to below 41%. The lumina of the covered Jostent, Palmaz, Sinus, and Symphony stents were completely obscured. The Impag, Perflex, and Strecker tantalum stents showed growing artifact sizes and a lumen reduction of at least 40% with increasing angulation to B0. CONCLUSIONS. Evaluation of the inner stent lumen by applying contrast-enhanced, three-dimensional gradient-echo sequences is not possible for the majority of stents because of their large artifacts. These depend on the stent type and orientation to B0. Even stents made of nitinol and cobalt alloys only allow qualitative patency assessment but no quantification of stenosis.

Contrast media research

This selective review highlights research in contrast media development and application in the field of diagnostic radiology in 1998 and 1999. The focus is on research published in Investigative Radiology, supplemented with work from other publications in the few areas not extensively covered by the journal. Studies continue to be performed, although at a low level, examining safety issues. Most preclinical investigations have focused on MR and ultrasound agents. In MR, the research effort is concentrated on the development of targeted agents; in ultrasound, work is focused on the characterization of basic contrast mechanisms. The demonstration of clinical applications is still dominated by work with MR, both in disease models and human investigations. The use of extracellular gadolinium chelates to enhance visualization of blood vessels (the field of contrast-enhanced MR angiography) is the largest single new clinical application of contrast media to emerge in several years. New clinical applications continue to be pursued with contrast media in CT, ultrasound, and x-ray angiography. As intravenously injected ultrasound contrast agents come to market, trials demonstrating clinical applications and subsequent scientific publications will increase in number.